- Home
- POCI vs PMN Comparison
POCI vs PMN Comparison
Compare POCI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- PMN
- Stock Information
- Founded
- POCI 1982
- PMN 2004
- Country
- POCI United States
- PMN Canada
- Employees
- POCI N/A
- PMN N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PMN Pharmaceuticals and Biotechnology
- Sector
- POCI Health Care
- PMN Health Care
- Exchange
- POCI Nasdaq
- PMN Nasdaq
- Market Cap
- POCI 35.1M
- PMN 17.0M
- IPO Year
- POCI N/A
- PMN N/A
- Fundamental
- Price
- POCI $4.83
- PMN $0.45
- Analyst Decision
- POCI
- PMN Strong Buy
- Analyst Count
- POCI 0
- PMN 2
- Target Price
- POCI N/A
- PMN $4.50
- AVG Volume (30 Days)
- POCI 19.1K
- PMN 50.5K
- Earning Date
- POCI 05-15-2025
- PMN 08-07-2025
- Dividend Yield
- POCI N/A
- PMN N/A
- EPS Growth
- POCI N/A
- PMN N/A
- EPS
- POCI N/A
- PMN N/A
- Revenue
- POCI $17,626,155.00
- PMN N/A
- Revenue This Year
- POCI N/A
- PMN N/A
- Revenue Next Year
- POCI N/A
- PMN N/A
- P/E Ratio
- POCI N/A
- PMN N/A
- Revenue Growth
- POCI N/A
- PMN N/A
- 52 Week Low
- POCI $3.47
- PMN $0.43
- 52 Week High
- POCI $6.59
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- POCI 56.10
- PMN 33.76
- Support Level
- POCI $4.43
- PMN $0.48
- Resistance Level
- POCI $5.08
- PMN $0.50
- Average True Range (ATR)
- POCI 0.33
- PMN 0.03
- MACD
- POCI 0.02
- PMN -0.00
- Stochastic Oscillator
- POCI 73.68
- PMN 0.00
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.